Lemborexant for insomnia in people with psychiatric conditions
Official title: A Multicenter, Prospective, Single-Arm, Observational Study on Effectiveness and Safety of Lemborexant on Insomnia Patients With Psychiatric Disorders
Run by Shanghai Mental Health Center · NCT07417813 · Data updated 2026-11-12
We will try lemborexant for 8 weeks in adults with psychiatric disorders who have insomnia to see if it helps them sleep better and is safe.
Quick facts
| Study type | Observational |
|---|---|
| Ages | 18 Years and up |
| Sex | All |
| Enrollment | 121 (estimated) |
| Sponsor | Shanghai Mental Health Center Academic / other |
| Locations | 9 sites (Suzhou, Jiangsu and 8 other locations) |
| Status | Recruiting |
| Started | January 24, 2026 |
| Main results expected | August 31, 2026 |
| Study ends | December 31, 2026 |
| Registry record updated | February 18, 2026 |
| Trial ID | NCT07417813 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Adults aged 18 or older who meet DSM-5 criteria for a psychiatric disorder, have an ISI score ≥11, can commit to roughly 8 weeks of treatment and follow-up, and whose clinicians plan to start lemborexant are the intended participants.
✕Probably not a fit
Patients in an acute psychiatric episode or with unstable psychotropic dosing, high suicide risk, narcolepsy, severe liver failure, pregnancy or breastfeeding, recent DORA use, or concurrent use of multiple benzodiazepine-receptor agonists are unlikely to benefit or be appropriate for this protocol.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This is a multicenter, prospective, single-arm observational study enrolling about 121 adults with psychiatric disorders and an Insomnia Severity Index (ISI) score of 11 or higher. Participants will receive lemborexant tablets for 8 weeks with scheduled scale-based assessments (including ISI and visual analogue scales) and safety monitoring for adverse events. The study is intended to capture real-world effectiveness and tolerability in a clinically diverse psychiatric population rather than a randomized comparison. Data will be collected across several hospitals in Shanghai and Jiangsu and used to inform clinical use of lemborexant in patients with comorbid psychiatric illness.
Why it matters
Potential benefit: If successful, the study could show that lemborexant improves sleep in people with psychiatric disorders and offers a safer alternative to benzodiazepine-type sleep drugs.
How similar studies have gone: Other randomized trials of lemborexant and similar dual orexin receptor antagonists have shown efficacy for primary insomnia, but real-world data specific to patients with comorbid psychiatric disorders remain limited.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: 1. Aged 18 years and above, regardless of gender; 2. Meet the DSM-5 diagnostic criteria for mental disorders (any type); 3. Insomnia Severity Index (ISI) score ≥11; 4. Have at least 7 hours of sleep time available; 5. Able to complete the 2-month scale assessment and follow-up plan; 6. Voluntarily sign the informed consent form; 7. Intend to receive lemborexant treatment as judged by the clinicians Exclusion Criteria: 1. Mental disorder is in the acute phase as judged by clinical assessment, or the dose of other psychotropic drugs cannot be stabilized during the study; 2. Concurrent use of ≥2 types of benzodiazepine receptor agonists (BZRAs) as insomnia treatment drugs; 3. Previous continuous use of dual orexin receptor antagonist (DORA)-type drugs for \>1 week; 4. Clear suicide attempt/plan or high suicide risk as judged by the researcher; 5. Pregnant or lactating women; 6. Patients with narcolepsy; 7. Patients with severe hepatic insufficiency; 8. Currently accompanied by severe or unstable diseases of cardiovascular, respiratory, digestive and other systems; 9. Other conditions deemed unsuitable for participation by the researcher
Where it's running
-
Suzhou GuangJi Hospital
Suzhou, Jiangsu, China Recruiting -
Xuzhou Oriental People's Hospital
Xuzhou, Jiangsu, China Recruiting -
Shanghai Mental Health Center
Shanghai, Shanghai Municipality, China Recruiting -
Renji Hospital Affiliated to Shanghai Jiao Tong University School of Medicine
Shanghai, Shanghai Municipality, China Recruiting -
Shanghai Pudong New Area Mental Health Center
Shanghai, Shanghai Municipality, China Recruiting -
Shanghai Fengxian District Mental Health Center
Shanghai, Shanghai Municipality, China Recruiting
Show 3 more locations
-
Sir Run Run Shaw Hospital Affiliated to Zhejiang University School of Medicine
Hangzhou, Zhejiang, China Recruiting -
The Second Affiliated Hospital of Zhejiang University School of Medicine
Hangzhou, Zhejiang, China Recruiting -
The First Affiliated Hospital of Ningbo University
Ningbo, Zhejiang, China Recruiting
Study contacts
- Study coordinator: Wenzheng Wang, PhD
- Email: fffty@163.com
- Phone: 18017311500
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Testing melatonin and low-dose quetiapine for insomnia in patients with psychiatric disorders
This study is testing whether melatonin and a low dose of quetiapine can help people with psychiatric disorders sleep better compared to a placebo.
-
SleepCogni for children with chronic insomnia
A handheld SleepCogni device is tested to see if it helps kids aged 6–16 with chronic insomnia sleep better.
-
Music therapy after stroke
This trial tests whether adding music therapy to standard care helps stroke patients sleep better and feel less anxious or depressed while in the hospital.
-
Remote ischemic conditioning for post-stroke insomnia
A 136-person, randomized study will test whether a non-invasive arm-cuff procedure done twice daily for 90 days can improve sleep after a first ischemic stroke in adults 18–80.
-
Nurse-guided app-based brief behavioral therapy for insomnia in older adults
Aging adults with insomnia will be asked to try a nurse-supported, smartphone app therapy for four weeks to see if it helps with sleep.
-
Three rTMS approaches to lessen insomnia-related pain after exercise-induced muscle soreness
This study tests whether three different rTMS approaches can reduce pain sensitivity and improve recovery in adults with insomnia after inducing muscle soreness from exercise.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.